GALLI, Ubaldina
 Distribuzione geografica
Continente #
NA - Nord America 297
EU - Europa 244
AS - Asia 55
AF - Africa 3
Totale 599
Nazione #
US - Stati Uniti d'America 295
DK - Danimarca 49
CN - Cina 40
SE - Svezia 37
DE - Germania 27
UA - Ucraina 26
IE - Irlanda 20
AT - Austria 17
FR - Francia 17
IT - Italia 14
FI - Finlandia 12
GB - Regno Unito 12
KR - Corea 9
BE - Belgio 5
PL - Polonia 4
SN - Senegal 3
CA - Canada 2
PT - Portogallo 2
RS - Serbia 2
BD - Bangladesh 1
IN - India 1
IR - Iran 1
JP - Giappone 1
SG - Singapore 1
VN - Vietnam 1
Totale 599
Città #
Ann Arbor 71
Chandler 68
Beijing 28
Dublin 20
Vienna 17
Jacksonville 16
Dearborn 14
Ashburn 11
Princeton 7
Houston 6
Milan 6
Nyköping 6
Brussels 5
Wilmington 5
Medford 4
Villeurbanne 4
Warsaw 4
Boston 3
Falls Church 3
Torino 3
Boardman 2
Dresden 2
Fairfield 2
Guangzhou 2
Hefei 2
Monmouth Junction 2
Munich 2
Nanjing 2
New York 2
Norwalk 2
Philadelphia 2
Shanghai 2
Woodbridge 2
Ardabil 1
Buffalo 1
Dhaka 1
Dong Ket 1
Düsseldorf 1
Florence 1
Fremont 1
Grafing 1
Kharkiv 1
Lachine 1
Los Angeles 1
Montréal 1
Nanchang 1
Palaiseau 1
Redwood City 1
Rostock 1
San Mateo 1
Singapore 1
Tappahannock 1
Tianjin 1
Tokyo 1
Verona 1
Wuhan 1
Totale 350
Nome #
QUINOLIN-4 (1H) -ONE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASES 252
Identification of 2,3-diaminophenazine and of o-benzoquinone dioxime as the major in vitro metabolites of benzofuroxan 80
WATER SOLUBLE FUROXAN DERIVATIVES AS NO PRODRUGS 77
Synthesis and antimalarial activities of some furoxan sulfones and related furazans 77
Unsymmetrically substituted furoxans. Part 16 [1]. Reaction of benzenesulfonyl substituted furoxans with ethanol and ethanethiol in basic medium 72
Design, Synthesis, and Biological Evaluation of New (2E,6E)-10-(Dimethylamino)-3,7-dimethyl-2,6-decadien-1-ol Ethers as Inhibitors of Human and Trypanosoma cruzi Oxidosqualene Cyclase. 69
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 2
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry 2
Synthesis and biological evaluation of isosteric analogues of FK866, an inhibitor of NAD salvage 1
Design, synthesis, and biological evaluation of combretabenzodiazepines: a novel class of anti-tubulin agents 1
Identification of a sirtuin 3 inhibitor that displays selectivity over sirtuin 1 and 2 1
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 1
Characterization of NAD uptake in mammalian cells 1
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 1
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 1
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 1
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 1
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis 1
Drug Discovery for Soft Drugs on TRPV1 and TRPM8 Channels Using the Passerini Reaction 1
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 1
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 1
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 1
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 1
Totale 646
Categoria #
all - tutte 2.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 5 4
2019/2020115 1 2 8 5 11 17 17 8 12 15 9 10
2020/202141 3 1 5 1 3 2 2 0 11 2 3 8
2021/2022147 10 10 5 11 15 9 17 11 4 16 19 20
2022/2023128 22 16 7 15 9 28 8 4 13 1 5 0
2023/202445 7 8 0 0 1 3 17 6 1 2 0 0
Totale 646